These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34607954)

  • 1.
    He Y; Rivera J; Diossy M; Duan H; Bowman-Colin C; Reed R; Jennings R; Novak J; Tran SV; Cohen EF; Szuts D; Giobbie-Hurder A; Bronson RT; Bass AJ; Signoretti S; Szallasi Z; Livingston DM; Pathania S
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34607954
    [No Abstract]   [Full Text] [Related]  

  • 2. A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier State.
    Liu Y; Yen HY; Austria T; Pettersson J; Peti-Peterdi J; Maxson R; Widschwendter M; Dubeau L
    EBioMedicine; 2015 Oct; 2(10):1318-30. PubMed ID: 26629527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach.
    Cao L; Xu X; Cao LL; Wang RH; Coumoul X; Kim SS; Deng CX
    Carcinogenesis; 2007 Jul; 28(7):1401-7. PubMed ID: 17363841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.
    Wistuba II; Tomlinson GE; Behrens C; Virmani A; Geradts J; Blum JL; Minna JD; Gazdar AF
    Genes Chromosomes Cancer; 2000 Aug; 28(4):359-69. PubMed ID: 10862044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
    Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
    J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice.
    Cressman VL; Backlund DC; Avrutskaya AV; Leadon SA; Godfrey V; Koller BH
    Mol Cell Biol; 1999 Oct; 19(10):7061-75. PubMed ID: 10490643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.
    Couto SS; Cao M; Duarte PC; Banach-Petrosky W; Wang S; Romanienko P; Wu H; Cardiff RD; Abate-Shen C; Cunha GR
    Differentiation; 2009 Jan; 77(1):103-11. PubMed ID: 19281769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
    Carraro DM; Koike Folgueira MA; Garcia Lisboa BC; Ribeiro Olivieri EH; Vitorino Krepischi AC; de Carvalho AF; de Carvalho Mota LD; Puga RD; do Socorro Maciel M; Michelli RA; de Lyra EC; Grosso SH; Soares FA; Achatz MI; Brentani H; Moreira-Filho CA; Brentani MM
    PLoS One; 2013; 8(3):e57581. PubMed ID: 23469205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice.
    Fong LY; Jiang Y; Farber JL
    Carcinogenesis; 2006 Jul; 27(7):1489-96. PubMed ID: 16543248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
    Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis.
    Triplett AA; Montagna C; Wagner KU
    Neoplasia; 2008 Dec; 10(12):1325-34. PubMed ID: 19048111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors.
    Upton DH; Fuller ES; Colvin EK; Walters KA; Jimenez M; Desai R; Handelsman DJ; Howell VM; Allan CM
    Horm Cancer; 2015 Aug; 6(4):142-52. PubMed ID: 25943777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal Squamous Cancer from 4NQO-Induced Mice Model: CNV Alterations.
    Liu Z; Su R; Ahsan A; Liu C; Liao X; Tian D; Su M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
    Jeng YM; Cai-Ng S; Li A; Furuta S; Chew H; Chen PL; Lee EY; Lee WH
    Oncogene; 2007 Sep; 26(42):6160-6. PubMed ID: 17420720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
    Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
    Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations.
    Ditchi Y; Broudin C; El Dakdouki Y; Muller M; Lavaud P; Caron O; Lejri D; Baynes C; Mathieu MC; Salleron J; Benusiglio PR
    Breast J; 2019 Jan; 25(1):16-19. PubMed ID: 30414230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
    Xing D; Orsulic S
    Cancer Res; 2006 Sep; 66(18):8949-53. PubMed ID: 16982732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
    Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
    Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.